Regulatory Issues

Laurie Burke, R.Ph., M.P.H.

Chief of Managed Care Outcome and Labeling, Drug Marketing, Advertising, and Communication Division

Center for Drug Evaluation and Research

U.S. Food and Drug Administration


Relationship Between Managed Care Formularies and Treatment Outcomes

Susan Horn, Ph.D.

Senior Scientist, Institute for Clinical Outcomes Research

Vice President of Research for International Severity Information Systems

Professor of Medical Informatics, University of Utah School of Medicine


Bacterial Resistance, the Antibiotic Formulary, and Other Management Strategies

Jerome Schentag, Pharm. D.

Director, Clinical Pharmacokinetics Laboratory

Millard Fillmore Health System

Professor of Pharmaceutics and Pharmacy

State University of New York at Buffalo


The Economics of Restrictions on Pharmaceuticals

Douglas L. Cocks, Ph.D.

Senior Research Scientist for Health Economics

Eli Lilly & Company





10:00 a.m.–12:00 noon GENERAL DISCUSSION


General Discussion

Moderator: Joshua Lederberg, Ph.D., Forum Chair


Summary of Sessions by Panel Moderators

Panel I: Basic and Clinical Research Frederick Sparling, M.D.

Panel II: Clinical Practice Guidelines Vincent Ahonkhai, M.D.

Panel III: Surveillance and Monitoring Carlos Lopez, Ph.D.

Panel IV: Education and Outreach Renu Gupta, M.D.

Panel V: Drug Formularies David Shlaes, M.D., Ph.D.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement